Minimally invasive pituitary surgery in a hemorrhagic necrosis of adenoma during pregnancy

Minimally Invasive Neurosurgery

Volumn 46, Issue 3, 2003, Pages 173-176

  Gondim, J ^a   Ramos Jr , F ^b   Pinheiro, I ^b   Schops, M ^b   Tella Jr , O I ^b  

^a Instituto de Neurologia   (Brazil)

^b NONE

Author keywords

Endoscope; Minimally invasive; Pituitary apolexy; Pregnancy

Indexed keywords

BROMOCRIPTINE;

ADENOMA; ADULT; ARTICLE; BRAIN HEMATOMA; CANCER CHEMOTHERAPY; CASE REPORT; DELIVERY; ENDOSCOPY; FEMALE; HEADACHE; HUMAN; HYPOPHYSECTOMY; MINIMALLY INVASIVE SURGERY; OCULOMOTOR NERVE; OPHTHALMOPLEGIA; OPTIC NERVE; THIRD TRIMESTER PREGNANCY; TRANSSPHENOIDAL SURGERY; TUMOR NECROSIS; VISUAL IMPAIRMENT;

ADULT; BROMOCRIPTINE; FEMALE; HEMATOMA; HEMORRHAGE; HORMONE ANTAGONISTS; HUMANS; NECROSIS; NEUROSURGICAL PROCEDURES; OPTIC NERVE NEOPLASMS; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROLACTINOMA; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 0042665468     PISSN: 09467211     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40734     Document Type: Article

References (50)

1. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL (ed). Functional Endocrine Pathology. Boston: Blackwell Sciences, 1991: 245-281
2. Molith ME. Management of prolactinomas during pregnancy. J Reprod Med 1999; 44: 1121-1126
3. Randeva H, Davis M, Prelevic G. Prolactinoma and pregnancy. Br J Obs Gyn 2000; 107: 1064-1068
4. Ester AD, Sanders TG, Vines FS. Size and shape of the pituitary gland during pregnancy and post partum: Measurement with MR imaging. Radiology 1991; 181: 531-532
5. Miki Y, Asato R, Okumura R. Anterior pituitary gland in pregnancy: Hyperintensity at MR. Radiology 1993; 187: 223-229
6. Dinç H, Esen F, Demirci A. Pituitary dimensions and volume measurements in pregnancy and post partum. Acta Radiol 1998; 39: 64-69
7. Vician L, Shupnik M, Gorski J. Effects of estrogen on primary ovine pituitary cell cultures: Stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 1979; 104: 736-743
8. Maurer R. Relationship between estradiol, ergocryptine, and thyroid hormone: Effects on prolactin synthesis and prolactin messenger ribonucleic acid levels. Endocrinology 1982; 110: 1515-1520
9. Rakoff J, Yen S. Progesterone induced acute release of prolactin in estrogen primed ovariectomized women. J Clin Endocrinol Metab 1978; 47: 918-922
10. Asa S, Penz C, Kovacs K, Ezrin C. Prolactin cells in the human pituitary: a quantitative immunocytochemical analysis. Arch Pathol Lab Med 1982; 106: 360-363
11. Pressman E, Zeidman S, Reddy U, Epstein J, Brem H. Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient. J Reprod Med 1995; 40: 251-259
12. Thorner MO, Perryman RI, Rogol AD, Conway BP, Macleod RM, Login IS. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981; 53: 480-483
13. Shanis BS, Check JH. Relative resistance of a microprolactinoma to bromocriptine therapy during pregnancy. Gynecol Endocrinol 1996; 10: 91-94
14. Gemzell C, Wang CF. Outcome of pregnancy in women pituitary adenomas. Fertil Steril 1979; 31: 363-372
15. Ahmed M, Al-Dossary E, Woodhouse NJ. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies. Fertil Steril 1992; 58: 492-497
16. Cunnah D, Besser M. Management of prolactinoma. Clin Endocrinol (Oxf) 1990; 34: 231-235
17. Ruiz-Velasco V, Tolis G. Pregnancy in hyperprolactinemic women. Fertil Steril 1984; 41: 793-805
18. Molith ME. Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985; 312: 1364-1370
19. Bergh T, Nillus SJ, Enoksson P, Larson G, Wide L. Bromocriptin-induced pregnancies in women with large prolactinomas. Clin Endocrinol (Oxf) 1982; 17: 625-631
20. Child D, Gordon H, Mashiter K, Joplin G. Pregnancy, prolactin and pituitary tumors. Br Med J 1975; 4: 87-89
21. Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. Proc of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, October 1988
22. Konopka P, Raymond J, Meceron R. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983; 146: 935-938
23. th International Pituitary Congress, Long Beach, California. 1999
24. van Roon E, van der Vijver JC, Gerretsen G, Hekster RE, Waddendorff RA. Rapid regression of a suprasellar estending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril 1981; 36: 173-177
25. Crosignani PG, Mattei AM, Severini V, Cavioni V, Maggioni P, Testa G. Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. Eur J Obs Rep Biology 1992; 40: 175-180
26. Modena G, Portioli I. Delivery after bromocriptine therapy. Lancet 1977; 2: 558
27. Yuen B. Bromocriptine, pituitary tumours, and pregnancy. Lancet 1978; 2: 1314
28. Griffith RW, Turkalj I, Braun P. Outcome of pregnancy in mothers given bromocriptine. Br J Clin Pharmacol 1978; 5: 227-231
29. Parks D. Drug therapy: bromocriptine. New Engl J Med 1979; 301: 873-878
30. Turkalj I, Braun P, Krupp P. Surveillance of bromocriptine in pregnancy. JAMA 1982; 247: 1589-1591
31. Raymond JP, Goldsteine E, Kanopka P, Lelu MF, Merceron RE, Loria Y. Follow up of children born of bromocriptine-treated mothers. Horm Res 1985; 22: 239-246
32. Freeman R, Wezenter B, Silverstein M, Kuo D, Weiss K, Kantrowitz A. Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus. Fertil Steril 1992; 58: 427-429
33. Labauge R, Pages A, Pages M, Ribstein J, Richard L. Necrose hemorragique d'un adenome hypophysaire polyoncose endocrinienne. Rev Neurol (Paris) 1982; 138: 149-158
34. Saunders N. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy. Postgrad Med J 1985; 61: 829-830
35. Wykes W. Prolactinoma presenting with intermittent third nerve palsy. Br J Ophthalmol 1986; 70: 706-707
36. Fong L, Fabinyi G. Ophthalmic manifestations of pituitary apoplexy. Med J Aust 1985; 142: 142-143
37. Crosignani PG, Ferrari C, Mattei AM. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case report. Br J Obstet Gynecol 1984; 91: 821-823
38. Holgren U, Bergstrand G, Hagenfeldt K, Werner S. Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and tumor growth. Acta Endocrinol 1986; 111: 452-459
39. Rasmussen C, Bergh T, Wide L. Prolactin secretion and menstrual function after long-term bromocriptine treatment. Fertil Steril 1987; 48: 550-554
40. Crosignani P, Mattei A, Scarduelli C, Cavioni V, Boracchi P. Is pregnancy the best treatment for hyperprolactinaemia? Human Reprod 1989; 4: 910-912
41. Divers W, Yen S. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 1983; 61: 425-429
42. Kupersmith MJ, Rosemberg C, Keimberg D. Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 1994; 121: 437
43. Rjosk H, Fahlbusch R, Werder K. Influence of pregnancies on prolactinomas. Acta Endocrinol 1982; 100: 337-346
44. Canales ES, Garcia IC, Ruiz JE, Zarate A. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil Steril 1981; 36: 524-526
45. Bergh T, Nillius S, Larsson S, Wide L. Effects of bromocriptine induced pregnancy on prolactin secreting pituitary tumors. Acta Endocrinol (Copenh) 1981; 98: 333-338
46. Goodman LA, Chang RJ. Pregnancy after bromocriptine induced reduction of an extrasellar prolactin-secreting pituitary macroadenomas. Obstet Gynecol 1984; 64 (3 Suppl): 2s-7s
47. Coremblum B. Successful outcome of ergocryptine-induced pregnancies in twenty-one women with prolactina-secreting pituitary adenomas. Fertil Steril 1979; 32: 183-186
48. Glick RP, Tiesi JÁ. Subacute pituitary apoplexy: clinical and magnetic resonance imaging characteristics. Neurosurgery 1990; 27: 214-219
49. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurg 1990; 26: 990-996
50. Gondim J, Pinheiro I. Neuroendoscopic endonasal transseptal approach to the sellar region: study of 30 cases. Arq Neuropsiquiatr 2001; 59: 901-904